Skip to main content

Advertisement

Table 1 Comparison between diabetic patients with and without MVC and controls as regards age, disease duration and laboratory findings.

From: Plasma Adrenomedullin level in Egyptian children and Adolescents with type 1 diabetes mellitus: relationship to microvascular complications

Variable Tests Group 1 Patients with MVC (N = 15) Group 2 Patients without MVC(N = 40) Controls (N = 30)  
Male/Female 7/8 26/14 17/13  
  Mean ± SD Mean ± SD Mean ± SD P
Age (yrs) 17.13 ± 1.5 12.73 ± 2.7 12.83 ± 2.4 P1 < 0.001, P2 < 0.001, P3 > 0.05*
BMI(Kg/m2) 21.39 ± 3.25 23.27 ± 3.8 22.11 ± 3.23 P > 0.05*
Systolic BP percentile 70.48 ± 21.7 66.4 ± 26.4 67.5 ± 23.23 P > 0.05*
Diastolic BP percentile 68.84 ± 13.6 64.7 ± 19.8 66 ± 18.3 P > 0.05*
Duration of diabetes (yrs) 9.6 ± 3.3 3.8 ± 3.8 - P < 0.001*
HbA1c (%) 9.36 ± 1.8 8.09 ± 2.02 4.2 ± 0.4 P < 0.05*
AM (pg/mL) 110.6 ± 94.24 60.25 ± 31.76 39.2 ± 12.43 Z1-2.01, Z2-2.7, Z3-3.37 P1 = 0.04, P2 < 0.01, P3 = 0.001#
  1. SD, standard deviation; BMI, body mass index;*Student t test; # Wilcoxon signed-rank test (Z value), Z1, P1 between groups 1&2; Z2, P2 between groups 1 & controls; Z3, P3 between group 2 & controls.